In this project, various questions regarding the efficacy of approved multiple sclerosis (MS) therapies were analyzed. This included descriptive analyses of...
Using the largest cohort of people with MS and COVID-19 available, we demonstrated consistent associations of rituximab with increased risk of hospitalization,...